Amita Nagaraj

CRS:

BJMC

Role:

Administrative and Finance

Position:

Sr. Finance Administrator, BJMC CRS

Email:

anagara8@jhmi.edu

Ms. Nagaraj (Seymour) has a Bachelor’s degree in Commerce majoring in Accounting has fourteen years of experience in budgeting and monitoring all financial and administrative aspects of the BJMC Subcontracts. She is currently the Sr.Financial Administrator for the BJMC CRS India. She is responsible for preparing all budgets and justifications for BJMC CRS; ensure that it is in compliant with the sponsor’s procurement requirements; oversees HR to see that for staff contracts, payroll, taxes are done on time; ensure that all expenses are correctly and timely recorded; overseas the prepare and reconcile of BJMC CRS project accounts and monthly invoice sent to the John Hopkins University. See that BJMC CRS audits are done in a timely manner.For John Hopkins University (JHU) Pune office prepares budgets and its justification for network and other studies undertaken by the JHU, Pune office; in charge of staff contracts and payroll, procurement and payments; taking care that time audit are done. She provide assistance and documentation to Ms.Smit in the preparation of budget projections and trends; ensure the financial activities and procedures are in compliance with sponsor’s regulations; assist in the process of preparing the annual financial reports and annual progress reports due to the sponsor.

Categories

Leadership Committees
CRS
Roles

Clinical Trials

A5288: MULTIOCTAVE, Management Using the Latest Technologies...

The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...

Read More

NWCS 445: Novel Biomarkers to Shorten TB Treatment

Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...

Read More

A5329: Interferon –Free Therapy for Chronic Hepatitis C...

A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...

Read More

A5314: Effect of LDMTX on Inflammation in HIV-infected...

A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...

Read More

A5279, Phase III Clinical Trial of Ultra-Short-Course...

This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...

Read More